• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二代药物洗脱支架植入后支架外斑块特征对血管反应的影响:iMAP-血管内超声和血管内镜研究

Impact of out-stent plaque characteristics on vascular response after second generation drug-eluting stent implantation: iMAP-intravascular ultrasound and angioscopic study.

作者信息

Kawai Kenji, Ichikawa Minoru, Masuyama Tohru, Ishihara Masaharu, Kijima Yoshiyuki

机构信息

Department of Cardiology, Higashi-osaka City Medical Center, 3-4-5 Nishi Iwata, Higashi-osaka, Osaka 578-8588, Japan.

Division of Cardiovascular Medicine and Coronary Heart Disease, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.

出版信息

Int J Cardiol Heart Vasc. 2018 May 25;19:83-87. doi: 10.1016/j.ijcha.2018.05.004. eCollection 2018 Jun.

DOI:10.1016/j.ijcha.2018.05.004
PMID:29892708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5993171/
Abstract

PURPOSE

The purpose of this study is to elucidate the impact of out-stent plaque characteristics on vascular response after implantation of second generation drug-eluting stent (G2-DES).

METHODS

Enrolled were 37 patients with 39 coronary artery lesions into which three types of G2-DES were successfully implanted (9 Nobori biolimus-, BES; 15 Xience everolimus-, EES; 15 Resolute zotarolimus-eluting stents; R-ZES). Immediately after (baseline) and one year after the implantation (follow-up), iMAP-intravascular ultrasound (IVUS) was performed to measure out-stent plaque volume (OSPV) and its components. Percent OSPV and vulnerable plaque index (VPI) were defined as percentile of OSPV to vessel volume and as percentile of lipidic plus necrotic volume to OSPV. Coronary angioscopy at follow-up rated the degree of arterial repair by neointimal stent coverage (NSC).

RESULTS

Poor NSC was found in approximately 60% of each G2-DES. In BES, % OSPV at baseline was significantly greater in poor NSC than in good NSC (36.2 ± 3.9 vs. 27.3 ± 4.0%, P = 0.01). In EES, %OSPV was significantly greater in poor NSC than in good NSC (41.0 ± 4.1 vs. 32.6 ± 2.7%, P < 0.01). In R-ZES implantation, there was no significant difference with regards to %OSPV between poor and good NSC. In BES, VPI at baseline was significantly greater in poor NSC than good NSC (54.0 ± 5.8 vs. 42.2 ± 5.1%, P = 0.02). There was no significant difference with regards to VPI between poor and good NCS in EES and R-ZES.

CONCLUSIONS

Impact of out-stent plaque characteristics on vascular response was different among the three types of G2-DES.

摘要

目的

本研究旨在阐明第二代药物洗脱支架(G2-DES)植入后支架外斑块特征对血管反应的影响。

方法

纳入37例患者的39处冠状动脉病变,成功植入三种类型的G2-DES(9枚Nobori生物雷帕霉素洗脱支架,BES;15枚Xience依维莫司洗脱支架,EES;15枚Resolute佐他莫司洗脱支架,R-ZES)。在植入后即刻(基线)和植入后一年(随访),进行iMAP血管内超声(IVUS)测量支架外斑块体积(OSPV)及其成分。OSPV百分比和易损斑块指数(VPI)分别定义为OSPV占血管体积的百分比以及脂质加坏死体积占OSPV的百分比。随访时的冠状动脉血管镜检查通过新生内膜支架覆盖(NSC)对动脉修复程度进行评级。

结果

每种G2-DES中约60%的患者NSC较差。在BES中,基线时NSC较差组的OSPV百分比显著高于NSC良好组(36.2±3.9 vs. 27.3±4.0%,P = 0.01)。在EES中,NSC较差组的OSPV百分比显著高于NSC良好组(41.0±4.1 vs. 32.6±2.7%,P < 0.01)。在R-ZES植入中,NSC较差组和良好组之间的OSPV百分比无显著差异。在BES中,基线时NSC较差组的VPI显著高于NSC良好组(54.0±5.8 vs. 42.2±5.1%,P = 0.02)。在EES和R-ZES中,NSC较差组和良好组之间的VPI无显著差异。

结论

三种类型的G2-DES中,支架外斑块特征对血管反应的影响有所不同。

相似文献

1
Impact of out-stent plaque characteristics on vascular response after second generation drug-eluting stent implantation: iMAP-intravascular ultrasound and angioscopic study.第二代药物洗脱支架植入后支架外斑块特征对血管反应的影响:iMAP-血管内超声和血管内镜研究
Int J Cardiol Heart Vasc. 2018 May 25;19:83-87. doi: 10.1016/j.ijcha.2018.05.004. eCollection 2018 Jun.
2
Angioscopic comparison of arterial repair after second-generation drug-eluting stent implantation into vulnerable and stable coronary plaques.第二代药物洗脱支架植入易损和稳定冠状动脉斑块后动脉修复的血管镜比较
Int J Cardiol. 2016 Oct 15;221:855-8. doi: 10.1016/j.ijcard.2016.07.089. Epub 2016 Jul 5.
3
Comparison of angioscopic findings among second-generation drug-eluting stents.第二代药物洗脱支架的血管内镜检查结果比较
J Cardiol. 2017 Sep;70(3):297-302. doi: 10.1016/j.jjcc.2016.11.012. Epub 2016 Dec 26.
4
Atherosclerotic change at one year after implantation of Endeavor zotarolimus-eluting stent vs. everolimus-eluting stent.安进公司的佐他莫司洗脱支架与依维莫司洗脱支架植入术后一年的动脉粥样硬化变化
Circ J. 2014;78(6):1428-36. doi: 10.1253/circj.cj-14-0085. Epub 2014 Apr 8.
5
Comparison of early-phase arterial repair following cobalt-chrome everolimus-eluting stent and slow-release zotarolimus-eluting stent: an angioscopic study.钴铬依维莫司洗脱支架与缓释佐他莫司洗脱支架早期动脉修复的比较:一项血管内镜研究。
Cardiovasc Interv Ther. 2018 Apr;33(2):163-168. doi: 10.1007/s12928-017-0465-x. Epub 2017 Mar 2.
6
Differential cutoff points and clinical impact of stent parameters of various drug-eluting stents for predicting major adverse clinical events: An individual patient data pooled analysis of seven stent-specific registries and 17,068 patients.不同药物洗脱支架支架参数对主要不良临床事件预测的临界值差异及临床影响:7 个支架特定注册研究和 17068 例患者的个体患者数据汇总分析。
Int J Cardiol. 2019 May 1;282:17-23. doi: 10.1016/j.ijcard.2019.01.108. Epub 2019 Feb 2.
7
Prospective randomized comparison of clinical and angiographic outcomes between everolimus-eluting vs. zotarolimus-eluting stents for treatment of coronary restenosis in drug-eluting stents: intravascular ultrasound volumetric analysis (RESTENT-ISR trial).前瞻性随机比较依维莫司洗脱支架与佐他莫司洗脱支架治疗药物洗脱支架内再狭窄的临床和血管造影结果:血管内超声体积分析(RESTENT-ISR 试验)。
Eur Heart J. 2016 Dec 1;37(45):3409-3418. doi: 10.1093/eurheartj/ehw389. Epub 2016 Sep 15.
8
Relative dose and vascular response after drug-eluting stent implantation: A dosimetric 3D-intravascular ultrasound study.
Int J Cardiol. 2016 Feb 1;204:211-7. doi: 10.1016/j.ijcard.2015.11.130. Epub 2015 Nov 30.
9
Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.生物可吸收聚丙交酯聚合物生物雷帕霉素 A9 洗脱支架与耐用聚合物依维莫司和佐他莫司洗脱支架在急性冠状动脉综合征患者中的安全性和有效性概况。
Catheter Cardiovasc Interv. 2016 Nov 15;88(6):E173-E182. doi: 10.1002/ccd.26617. Epub 2016 Jul 5.
10
ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).使用光学相干断层扫描(COVER OCT)比较佐他莫司洗脱支架和依维莫司洗脱支架的新生内膜覆盖率。
Am Heart J. 2012 Apr;163(4):601-7. doi: 10.1016/j.ahj.2011.10.016.

本文引用的文献

1
Angioscopic observation of extremely late arterial repair after intracoronary implantation of the first-generation sirolimus-eluting stents.第一代西罗莫司洗脱支架冠状动脉内植入术后极晚期动脉修复的血管内镜观察
Int J Cardiol. 2017 Mar 1;230:488-492. doi: 10.1016/j.ijcard.2016.12.077. Epub 2016 Dec 21.
2
Everolimus-eluting stents stabilize plaque inflammation in vivo: assessment by intravascular fluorescence molecular imaging.依维莫司洗脱支架可在体内稳定斑块炎症:通过血管内荧光分子成像进行评估。
Eur Heart J Cardiovasc Imaging. 2017 May 1;18(5):510-518. doi: 10.1093/ehjci/jew228.
3
Comparison of angioscopic findings among second-generation drug-eluting stents.
第二代药物洗脱支架的血管内镜检查结果比较
J Cardiol. 2017 Sep;70(3):297-302. doi: 10.1016/j.jjcc.2016.11.012. Epub 2016 Dec 26.
4
Angioscopic comparison of arterial repair after second-generation drug-eluting stent implantation into vulnerable and stable coronary plaques.第二代药物洗脱支架植入易损和稳定冠状动脉斑块后动脉修复的血管镜比较
Int J Cardiol. 2016 Oct 15;221:855-8. doi: 10.1016/j.ijcard.2016.07.089. Epub 2016 Jul 5.
5
Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).前蛋白转化酶枯草溶菌素9(PCSK9)抑制对冠状动脉粥样硬化进展的影响:通过血管内超声(GLAGOV)测量的PCSK9抗体对斑块消退的全球评估的原理和设计。
Am Heart J. 2016 Jun;176:83-92. doi: 10.1016/j.ahj.2016.01.019. Epub 2016 Feb 17.
6
In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy).支架内黄色斑块在植入后 1 年内与未来非常晚期支架失败事件相关:DESNOTE 研究(通过血管内超声检测药物洗脱支架未被新生内膜完全覆盖的非常晚期支架失败事件)。
JACC Cardiovasc Interv. 2015 May;8(6):814-821. doi: 10.1016/j.jcin.2014.12.239.
7
Characterization of patients with angioscopically-detected in-stent mural thrombi – genetics of clopidogrel responsiveness and generations of drug-eluting stents.血管镜检测到的支架内附壁血栓患者的特征——氯吡格雷反应性的遗传学与药物洗脱支架的代际情况
Circ J. 2015;79(1):85-90. doi: 10.1253/circj.CJ-14-0639. Epub 2014 Oct 30.
8
Coronary arterial remodeling and out-stent plaque change after drug-eluting stent implantation--comparison between zotarolimus-eluting stents and paclitaxel-eluting stents.药物洗脱支架置入术后冠状动脉重构和支架外斑块变化——比较佐他莫司洗脱支架和紫杉醇洗脱支架。
Circ J. 2013;77(2):363-71. doi: 10.1253/circj.cj-12-0575. Epub 2012 Oct 27.
9
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.药物洗脱支架和裸金属支架的支架血栓形成:来自综合网络荟萃分析的证据。
Lancet. 2012 Apr 14;379(9824):1393-402. doi: 10.1016/S0140-6736(12)60324-9. Epub 2012 Mar 23.
10
Relationship between tissue characterisations with 40 MHz intravascular ultrasound imaging and slow flow during coronary intervention.血管内超声 40MHz 成像的组织特征与冠状动脉介入治疗中慢血流的关系。
EuroIntervention. 2011 Jul;7(3):340-6. doi: 10.4244/EIJV7I3A58.